John Overdeck’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-27,803
| Closed | -$227K | – | 4775 |
|
|
2025
Q4 | $227K | Buy |
+27,803
| New | +$206K | ﹤0.01% | 3714 |
|
|
2021
Q3 | – | Sell |
-22,757
| Closed | -$256K | – | 4498 |
|
|
2021
Q2 | $256K | Sell |
22,757
-18,708
| -45% | -$216K | ﹤0.01% | 3618 |
|
|
2021
Q1 | $440K | Buy |
+41,465
| New | +$466K | ﹤0.01% | 3050 |
|
|
2020
Q3 | – | Sell |
-37,936
| Closed | -$302K | – | 3342 |
|
|
2020
Q2 | $302K | Buy |
+37,936
| New | +$391K | ﹤0.01% | 2374 |
|
|
2020
Q1 | – | Sell |
-60,893
| Closed | -$689K | – | 3507 |
|
|
2019
Q4 | $689K | Sell |
60,893
-7,231
| -11% | -$76.9K | ﹤0.01% | 2536 |
|
|
2019
Q3 | $741K | Sell |
68,124
-14,898
| -18% | -$162K | ﹤0.01% | 2235 |
|
|
2019
Q2 | $778K | Buy |
83,022
+38,521
| +87% | +$389K | ﹤0.01% | 2164 |
|
|
2019
Q1 | $546K | Buy |
+44,501
| New | +$543K | ﹤0.01% | 2212 |
|
|
2018
Q4 | – | Sell |
-41,096
| Closed | -$592K | – | 3290 |
|
|
2018
Q3 | $592K | Buy |
+41,096
| New | +$568K | ﹤0.01% | 2334 |
|
|
2017
Q4 | – | Sell |
-12,935
| Closed | -$168K | – | 3289 |
|
|
2017
Q3 | $168K | Sell |
12,935
-38,989
| -75% | -$514K | ﹤0.01% | 2618 |
|
|
2017
Q2 | $771K | Buy |
+51,924
| New | +$723K | ﹤0.01% | 2061 |
|
|
2016
Q3 | – | Sell |
-33,226
| Closed | -$358K | – | 3250 |
|
|
2016
Q2 | $358K | Buy |
33,226
+14,639
| +79% | +$161K | ﹤0.01% | 2459 |
|
|
2016
Q1 | $195K | Sell |
18,587
-17,271
| -48% | -$190K | ﹤0.01% | 2597 |
|
|
2015
Q4 | $424K | Buy |
+35,858
| New | +$440K | ﹤0.01% | 2062 |
|
|
2015
Q3 | – | Sell |
-46,680
| Closed | -$674K | – | 2482 |
|
|
2015
Q2 | $674K | Buy |
+46,680
| New | +$674K | ﹤0.01% | 1925 |
|
|
2014
Q4 | – | Sell |
-39,800
| Closed | -$488K | – | 2308 |
|
|
2014
Q3 | $488K | Buy |
39,800
+17,431
| +78% | +$218K | ﹤0.01% | 1305 |
|
|
2014
Q2 | $279K | Buy |
22,369
+10,664
| +91% | +$126K | ﹤0.01% | 1866 |
|
|
2014
Q1 | $131K | Sell |
11,705
-66
| -0.6% | -$724 | ﹤0.01% | 1857 |
|
|
2013
Q4 | $142K | Buy |
+11,771
| New | +$141K | ﹤0.01% | 2051 |
|
|
2013
Q3 | – | Sell |
-45,758
| Closed | -$604K | – | 1982 |
|
|
2013
Q2 | $604K | Buy |
+45,758
| New | +$633K | ﹤0.01% | 1311 |
|
Other funds holding LFCR
2L
WC
LPAM
GRIM
3C
GC
John Overdeck's LFCR Position: Q1 2026 in Review
John Overdeck sold out of Lifecore Biomedical (LFCR) in Q1 2026, closing a stake of 27,803 shares — an estimated $227K sold.
John Overdeck first reported a position in LFCR in Q2 2013 and held it in 20 quarters. The position peaked at $778K in Q2 2019. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.
- John Overdeck reported no remaining Lifecore Biomedical position as of Q1 2026 after selling out during the quarter.
- John Overdeck sold 27,803 Lifecore Biomedical shares in Q1 2026, an estimated $227K.
- John Overdeck first reported a position in Lifecore Biomedical in Q2 2013 and held it in 20 quarters.
- John Overdeck's Lifecore Biomedical position peaked at $778K in Q2 2019.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.